Condition
Neurodevelopmental Impairment
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Completed2
Unknown1
Withdrawn1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06915441Phase 2Recruiting
Lipid Infusions to Optimize Nutrition Trial
NCT03169881Phase 3Completed
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
NCT01282788Not ApplicableCompleted
Efficacy of Caterpillar Cereal for Complementary Feeding in the Democratic Republic of Congo
NCT01028183Withdrawn
Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability
NCT01193751Unknown
Apgar-Score in Asphyxiated Infants Under Resuscitation
Showing all 5 trials